4//SEC Filing
Chauche Thierry 4
Accession 0001104659-25-010584
CIK 0001400118other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:41 PM ET
Size
7.6 KB
Accession
0001104659-25-010584
Insider Transaction Report
Form 4
Chauche Thierry
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-06+69,000→ 69,000 totalExercise: $4.71Exp: 2035-02-05→ Series A Common Stock (69,000 underlying) - Award
Series A Common Stock
2025-02-06+17,000→ 17,000 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following February 6, 2025, subject to the Reporting Person's continued service on each such vesting date.
- [F2]The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following February 6, 2025, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Sagimet Biosciences Inc.
CIK 0001400118
Entity typeother
Related Parties
1- filerCIK 0001895174
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:41 PM ET
- Size
- 7.6 KB